2.8501.04% ( -0.030 )
延遲 已收盤: 11月20日 16:08:00股東
全部股東
股東類型
- 公眾及其他63.74%
- 個人與內幕人士16.41%
- 僱員持股計劃10.60%
- 創投/私募8.47%
- 機構投資者0.78%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Wenzhi TianFounder, CEO, Chief Scientific Officer & Chairman of the Board | 16.41% | 7,048.30 萬 | 0.00% | +0 | 16/11/2026 |
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. , ESOP | 10.60% | 4,552.43 萬 | 0.04% | -17.68 萬 | 16/11/2026 |
Shanghai Yongkan Investment Management Co., Ltd. | 8.47% | 3,639.23 萬 | 0.01% | +0 | 31/12/2025 |
GF Fund Management Co., Ltd. | 0.76% | 327.72 萬 | <0.01% | +0 | 30/06/2025 |
Fullgoal Fund Management Co. Ltd. | 0.02% | 8.86 萬 | <0.01% | +0 | 31/12/2025 |
Dimensional Fund Advisors LP | 0.00% | 0.00 | <0.01% | -1.88 萬 | 30/09/2026 |
State Street Investment Management | 0.00% | 0.00 | 0.19% | -81.16 萬 | 21/11/2026 |
